Comparison of Femoral Nerve Block and Combined PENG Plus Femoral Nerve Block in Geriatric Hip Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorAnkara City Hospital Bilkent

About this trial

Hip fracture surgery in geriatric patients is frequently associated with severe perioperative pain, which may complicate positioning for spinal anesthesia and increase perioperative opioid requirements. Regional analgesic techniques are commonly used to improve patient comfort and reduce opioid consumption in this vulnerable population. The femoral nerve block is a well-established method for analgesia in hip surgery, while the pericapsular nerve group (PENG) block has emerged as a novel technique targeting articular branches of the hip joint with potential advantages in pain control.

This prospective randomized controlled trial aims to compare the analgesic efficacy of femoral nerve block alone versus a combined pericapsular nerve group (PENG) plus femoral nerve block in geriatric patients undergoing hip fracture surgery under spinal anesthesia. The primary outcomes include perioperative pain intensity, opioid consumption within the first 24 hours postoperatively, and the need for additional analgesia during positioning for spinal anesthesia. Secondary outcomes include spinal anesthesia procedure duration, time to sensory block onset, time to first postoperative opioid requirement, and perioperative hemodynamic parameters.

The results of this study are expected to clarify whether the addition of the PENG block to femoral nerve block provides superior perioperative analgesia and improved patient comfort compared with femoral nerve block alone in geriatric hip fracture surgery.

Eligibility criteria

Qualifiers

Age 65 years and older,

Patients scheduled for surgery due to hip fracture,

American Society of Anesthesiologists (ASA) physical status I-III,

Body mass index between 18 and 40 kg/m²,

Disqualifiers

Age below 65 years,

Refusal to participate in the study,

Severe cognitive impairment, dementia, or Alzheimer's disease,

ASA physical status IV or higher,

Trial design

Treatments tested in this trial

  • Pericapsular nerve group (PENG) block plus femoral nerve block
  • Femoral Nerve Block

Treatment groups

68 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ankara City Hospital Bilkent

Lead sponsor

Ankara Bilkent Sehir Hastanesi

Sponsor institution